WestEnd Advisors LLC acquired a new position in UnitedHealth Group Inc. (NYSE:UNH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 671,456 shares of the healthcare conglomerate’s stock, valued at approximately $94,810,000. UnitedHealth Group accounts for about 5.0% of WestEnd Advisors LLC’s investment portfolio, making the stock its 6th largest position.
Several other hedge funds and other institutional investors have also modified their holdings of UNH. Bank of Montreal Can purchased a new stake in UnitedHealth Group during the second quarter valued at approximately $207,013,000. Dodge & Cox boosted its stake in UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock valued at $1,957,113,000 after buying an additional 1,324,136 shares during the last quarter. UBS Asset Management Americas Inc. boosted its stake in UnitedHealth Group by 13.0% in the first quarter. UBS Asset Management Americas Inc. now owns 4,424,657 shares of the healthcare conglomerate’s stock valued at $570,338,000 after buying an additional 508,995 shares during the last quarter. Omega Advisors Inc. purchased a new stake in UnitedHealth Group during the first quarter valued at approximately $64,386,000. Finally, Bridger Management LLC purchased a new stake in UnitedHealth Group during the first quarter valued at approximately $50,273,000. 85.80% of the stock is owned by institutional investors and hedge funds.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded up 6.90% during midday trading on Tuesday, hitting $143.39. 9,745,331 shares of the company were exchanged. The stock has a market cap of $136.56 billion, a PE ratio of 22.44 and a beta of 0.57. The stock’s 50-day moving average is $136.95 and its 200-day moving average is $136.65. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $144.48.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The company had revenue of $46.30 billion for the quarter, compared to analyst estimates of $46.09 billion. During the same quarter in the prior year, the business posted $1.77 EPS. UnitedHealth Group’s quarterly revenue was up 11.6% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Inc. will post $7.90 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a dividend of $0.625 per share. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.86%. UnitedHealth Group’s dividend payout ratio (DPR) is 39.12%.
Several analysts have commented on UNH shares. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, June 21st. Leerink Swann reissued a “buy” rating on shares of UnitedHealth Group in a research note on Monday, June 27th. Wolfe Research assumed coverage on shares of UnitedHealth Group in a research note on Tuesday, June 28th. They set an “outperform” rating and a $172.00 price objective for the company. Credit Suisse Group AG reissued a “buy” rating and set a $148.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Sanford C. Bernstein assumed coverage on shares of UnitedHealth Group in a research note on Friday, July 15th. They set an “outperform” rating for the company. One investment analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $155.35.
In other news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.65% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.